“De Novo Design and Molecular Dynamics Evaluation of AZ67-Derived Allosteric PFKFB3 Modulators for Anticancer Metabolic Drug Discovery”. Journal of Cancer Research Updates 15, no. 3 (August 27, 2026): 249–261. Accessed September 4, 2026. https://www.neoplasiaresearch.com/index.php/jcru/article/view/977.